REVIEW PAPER
A patient with a diagnosed patent ductus arteriosus – what next?
Publication date: 2018-03-19
Pediatr Pol 2018;93(1):86-93
KEYWORDS
ABSTRACT
Among congenital heart defects of the cardiovascular system, patent ductus arteriosus (PDA) comprises about 10% in the general population. Prematurity significantly raises the likelihood of PDA: in preemies of very low birth weight this defect appears with a frequency up to 65%, and in extremely low birth weight preemies up to 80%. Over a span of many years of research many different methods for treating PDA have been discovered, modified, and improved. Invasive treatment (thoracotomy, thoracoscopy, and percutaneous closure) as well as therapeutic strategies (symptomatic treatment, pharmacological treatment) allow for complete closure of PDA in every patient. The limitations of particular methods in regard to age and body mass of the child, their clinical state, as well as the morphology of the PDA itself, require careful analysis when choosing the appropriate treatment method based on the effectiveness and permanency of closing the duct as well as minimal invasiveness. Among preemies and newborns it is possible to close the PDA using symptomatic and pharmacological treatment as well as through thoracotomy and thoracoscopy, while in older children and adults the method of choice is the percutaneous closure of PDA. Matching the correct treatment strategy with the clinical situation is key to the successful closure of the duct. Presented in the text below is an overview of available methods and their usefulness in treating PDA.
REFERENCES (58)
1.
Michelakis ED, Rebeyka I, Wu X i wsp. O2 sensing in the human ductus arteriosus: Regulation of voltage-gated K+ channels in smooth muscle cells by a mitochondrial redox sensor. Circ Res 2002; 91: 478-486.
2.
Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006; 114: 1873-1882.
3.
Żyła-Frycz M. Wady przewodozależne. W: Kardiochirurgia dziecięca. Skalski JH, Religa Z (eds.). Wydawnictwo Naukowe Śląsk, Katowice 2003; 327-338.
4.
Mehtr S, Younoszai A, Pietz J, Achanti B. Pharmacological closure of the patent ductus arteriosus. Images Paediatr Cardiol 2003; 14: 1-15.
5.
Jędrzejek M, Sarbinowska J, Wiślińska K, Błaż W. Patent ductus arteriosus − not only a paediatric issue. Pediatr Med Rodz 2014; 10: 291-305.
6.
Matsui H, McCarthy K, Ho S. Morphology of the patent arterial duct: features relevant to treatment. Images Paediatr Cardiol 2008; 10: 27-38.
7.
Van Overmeire B, Chemtob S. The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 2005; 10: 177-184.
8.
Khositseth A, Nuntnarumit P, Chongkongkiat P. Echocardiographic parameters of patent ductus arteriosus in preterm infants. Indian Pediatr 2011; 48: 773-778.
9.
Philips JB. Pathophysiology, clinical manifestations, and diagnosis of patent ductus arteriosus in premature infants. In: UpToDate. Garcia-Prats JA, Fulton DR (ed.).
10.
Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006; 26 Suppl 1: S14-18; discussion S22-S23.
11.
Sekar KC, Corff KE. Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J Perinatol 2008; 28 Suppl 1: S60-S62.
12.
Sinha B. Controversies in Management of Patent Ductus Arterious in the Preterm Infant. J Pulm Respir Med 2013; S13: 007; doi: 10.4172/2161-105X.S13-007.
13.
Mazur W, Siegel MJ, Miszalski-Jamka T, et al. CT Atlas of adult congenital heart disease. Springer Science & Business Media, London 2013.
14.
Doyle T, Kavanaugh-McHugh A, Soslow J, et al. Management of patent ductus arteriosus. In: UpToDate. Triedman JK, Connolly HM (eds.) (Accessed in 2016).
15.
Rao PS. Percutaneous closure of patent ductus arteriosus − current status. J Invasive Cardiol 2011; 23: 517-520.
16.
Moss and Adams’ heart disease in infants, children, and adolescents. Allen HD, Driscoll DJ, Shaddy RE, et al. (eds.). Lippincott Williams & Wilkins, Philadelphia 2013.
17.
Fortescue EB, Lock JE, Galvin T, et al. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis 2010; 5: 354-365.
18.
Wojtalik M, Mrówczyński W, Skalski JH. Przetrwały przewód tętniczy. In: Kardiochirurgia dziecięca. Skalski JH, Religa Z (eds.). Wydawnictwo Naukowe Śląsk, Katowice 2003; 327-338.
19.
Aleszewicz-Baranowska J, Komorowska W. Podstawy diagnostyki kardiologicznej u dzieci. Forum Med Rodz 2007; 1: 242-249.
20.
Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125: 1020-1030.
21.
Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007; 92: F244-F247.
22.
Zalecenia Polskiego Towarzystwa Neonatologicznego: Standardy opieki medycznej nad noworodkiem w Polsce. Borszewska-Kornacka MK (ed.). Media-Press, Warszawa 2017.
23.
Controversies around treatment of the open duct. Springer Science & Business Media 2011; 200. Available from: https://books.google.com/books....
24.
Zahn EM, Nevin P, Simmons C, Garg R. A novel technique for transcatheter patent ductus arteriosus closure in extremely preterm infants using commercially available technology. Catheter Cardiovasc Interv 2015; 85: 240-248.
25.
Forbes TJ, Harahsheh A, Rodriguez-Cruz E, et al. Angiographic and Hemodynamic Predictors for Successful Outcome of Transcatheter Occlusion of Patent Ductus Arteriosus in Infants Less Than 8 Kilograms. Catheter Cardiovasc Interv 2004; 61: 117-122.
26.
Evans N. Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 2003; 3: 168-177.
27.
Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther 2007; 12: 138-146.
28.
Ibrahim TK, Haium AA, Chandran S, et al. Current controversies in the management of patent ductus arteriosus in preterm infants. Indian Pediatr 2014; 51: 289-294.
29.
Sakhalkar VS, Merchant RH. Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin. Indian Pediatr 1992; 29: 313-318.
30.
Park HJ, Jung YS, Kim NS, et al. A Comparative study of the effects of intravenous indomethacin and oral mefenamic acid in the treatment of premature infants with patent ductus arteriosus. Korean J Pediatr 2001; 44: 32-39.
31.
Abdel-Hady H, Nasef N, et al. Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers? Hindawi Publishing Corporation, BioMed Research International 2013; doi: http://dx.doi.org/10.1155/2013....
32.
Bouissou A, Rakza T, Klosowski S, et al. Hypotension in Preterm Infants with Significant Patent Ductus Arteriosus: Effects of Dopamine. J Pediatr 2008; 153: 790-794.
33.
Kaemmerer H, Meisner H, Hess J, Perloff J. Surgical treatment of Patent Ductus Arteriosus: A new historical perspective. Am J Cardiol 2004; 94: 1153-1154.
34.
Baruteau A-E, Hascoët S, Baruteau J, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis 2014; 107: 122-132.
35.
Taşar M, Yaman ND, Eyileten Z, et al. Surgery for patent ductus arteriosus in infants with very low birth weight. Cardiovasc Surg Int 2015; 2: 54-57.
36.
Chen H, Weng G, Chen Z, et al. Comparison of posterolateral thoracotomy and video-assisted thoracoscopic clipping for the treatment of patent ductus arteriosus in neonates and infants. Pediatric Cardiology 2011; 32: 386-390.
37.
Villa E, Eynden F Vanden, et al. Paediatric video-assisted thoracoscopic clipping of patent ductus arteriosus: Experience in more than 700 cases. Eur J Cardiothorac Surg 2004; 25: 387-393.
38.
Jacobs JP, Giroud JM, Quintessenza JA, et al. The Modern Approach to Patent Ductus Arteriosus Treatment: Complementary Roles of Video-Assisted Thoracoscopic Surgery and Interventional Cardiology Coil Occlusion. Ann Thorac Surg 2003; 76: 1421-1428.
39.
Laborde F, Noirhomme P, Karam J, et al. A new video-assisted thoracoscopic surgical technique for interruption of patient ductus arteriosus in infants and children. J Thorac Cardiovasc Surg 1993; 105: 278-280.
40.
Burke RP, Jacobs JP, Cheng W, et al. Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants. Pediatrics 1999; 104: 227-230.
41.
Nezafati MH, Mahmoodi E, Hashemian SH, et al. Video-assisted thoracoscopic surgical (VATS) closure of Patent Ductus Arteriosus: Report of three-hundred cases. Heart Surg Forum 2002; 5: 57-59.
42.
Dutta S, Mihailovic A, Benson L, et al. Thoracoscopic ligation versus coil occlusion for patent ductus arteriosus: A matched cohort study of outcomes and cost. Surg Endosc Other Interv Tech 2008; 22: 1643-1648.
43.
Kołtowski P, Patkowski D, Adamus J, et al. Thoracoscopic closure of patent ductus arteriosus in 2 premature infants weighing 700 and 800 g. Polish J Cardio-Thoracic Surg 2012; 4: 428-430.
44.
Vanamo K, Berg E, Kokki H, et al. Video-assisted thoracoscopic versus open surgery for persistent ductus arteriosus. J Pediatr Surg 2006; 41: 1226-1229.
45.
Vida VL, Rubino M, Bottio T, et al. Thoracoscopic closure of the patent arterial duct. Cardiol Young 2004; 14: 164-167.
46.
Nezafati MH, Soltani G, Vedadian A. Video-assisted ductal closure with new modifications: minimally invasive, maximally effective, 1,300 cases. Ann Thorac Surg 2007; 84: 1343-1348.
47.
Das MB, Kapoor L, Moulick A, et al. Video-assisted thoracoscopic surgery for closure of patent ductus arteriosus in children. Indian Heart J 1997; 49: 300-302.
48.
Yarrabolu RT. Transcatheter closure of patent ductus arteriosus. Pediatr Ther 2012; 01(S5).
49.
Rashkind WJ, Mullins CE, Hellenbrand WE, et al. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation1987; 75: 583-592.
50.
Szczeklik A, Tendera M. Kardiologia. Wydawnictwo Medycyna Praktyczna, Kraków 2009; 589.
51.
Cambier PA, Kirby WC, Wortham DC, et al. Percutaneous closure of the small (< 2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol 1992; 69: 815-816.
52.
Dimas VV, Takao C, Ing FF, et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing <6 kg. JACC Cardiovasc Interv 2010; 3: 1295-1299.
53.
Kusa J, Raś M, Cześniewicz P, et al. Less invasive percutaneous closure of persistent arterial duct in children below 10 kilos. Postep Kardiol Inter 2013; 9: 132-135.
54.
Francis E, Singhi AK, Lakshmivenkateshaiah S, et al. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 2010; 3:550-555.
55.
Ali SH, Abdalla SE. Percutaneous transcatheter closure of patent ductus arteriosus: Initial experience of Sohag University. Egypt Hear J 2014; 66: 143-147.
56.
Azhar AS, Abd El-Azim AA, Habib HS. Transcatheter closure of patent ductus arteriosus: evaluating the effect of the learning curve on the outcome. Ann Pediatr Cardiol 2009; 2: 36-40.
57.
Doshi AR, Rao PS. Development of aortic coarctation following device closure of patent ductus arteriosus. J Invasive Cardiol 2013; 25: 464-467.
58.
Park YA, Kim NK, Park J, et al. Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less. Korean J Pediatr 2010; 53: 1012-1027.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
